Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Nucleic Acids Research|August 13, 2013
ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategyJing Liu, Dongbo Yu, Yuichiro Aiba, et al.
Nucleic Acids Research|July 27, 2013
RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expressionJing Liu, Hannah Pendergraff, K Jayaprakash Narayanannair, et al.
Nucleic Acids Research|May 29, 2020
Analyzing pre-symptomatic tissue to gain insights into the molecular and mechanistic origins of late-onset degenerative trinucleotide repeat diseaseYongjun Chu, Jiaxin Hu, Hanquan Liang, et al.
The Prostate|January 1, 2010
Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancerYingming Li, Bahaa S Malaeb, Zhong-Ze Li, et al.
Nucleic Acid Therapeutics|March 24, 2020
Delivery of Antisense Oligonucleotides to the CorneaViet Q Chau, Jiaxin Hu, Xin Gong, et al.
Biological Chemistry|February 8, 2011
Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAsJiaxin Hu, Keith T Gagnon, Jing Liu, et al.
Cell|September 4, 2012
Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expressionDongbo Yu, Hannah Pendergraff, Jing Liu, et al.
Urologic Oncology|March 8, 2006
Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer modelBenjamin K Canales, Yingming Li, Melissa G Thompson, et al.
Nucleic Acid Therapeutics|January 18, 2018
Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded RepeatLiande Li, Xiulong Shen, Zhongtian Liu, et al.
The EMBO Journal|August 2, 2011
Regulation of TFEB and V-ATPases by mTORC1Samuel Peña-Llopis, Silvia Vega-Rubin-de-Celis, Jacob C Schwartz, et al.
Pageof 15